Viewing Study NCT01074424


Ignite Creation Date: 2025-12-18 @ 8:13 AM
Ignite Modification Date: 2025-12-23 @ 6:22 PM
Study NCT ID: NCT01074424
Status: None
Last Update Posted: 2010-02-24 00:00:00
First Post: 2010-02-23 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer
Sponsor: None
Organization:

Study Overview

Official Title: Development of a Serum Proteomic Profile for Cervical Cancer With Potential Prognostic Value
Status: None
Status Verified Date: 2010-02
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES:

Primary

* To develop a serum proteomic profile for cervical cancer using banked pre-treatment serum specimens from patients with invasive cervical cancer and to determine if this serum proteomic profile has possible utility in cervical cancer prognosis.

Secondary

* To develop a serum proteomic profile for cervical cancer using banked post-treatment serum specimens from these patients and to determine if this serum proteomic profile has possible utility in cervical cancer prognosis.

OUTLINE: This is a multicenter study.

Banked serum specimens are used to generate proteomic profiles.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: